A state-of-the-art technology developed by an expert from Hong Kong allows drug screening and discovery using a human heart-in-a-jar with genetic and immunologic make-up identical to the individual source.
A US FDA-approved ring oximeter developed by a start-up in Hong Kong enables screening of obstructive sleep apnoea (OSA) at home and can be used for treatment monitoring to enhance patients’ adherence.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Cardiology - Malaysia digital copy today!
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.